Abstract:Cefquinome Sulfate (CS) is a fourth-generation cephalosporin, which has been developed solely for veterinary use. It shows potent antibacterial activity against a broad spectrum of bacterial species. However, Cefquinome is susceptible to hydrolysis, which limiting its clinical employment efficacies to some extent. So, in this study, to increase Cefquinome Sulfate biological half-life, a novel Cefquinome Sulfate proliposome was prepared by solid dispersion and effervescent techniques and characterized for morphology, particle size, entrapment efficiency and in vitro release. A Reversed Phase-High Performance Liquid Chromatography (RP-HPLC) method was first chosen and established to determine the drug concentration in plasma after intra muscular (IM) administrating Cefquinome Sulfate solution and liposome at a single dosage of 18 mg/kg in rabbit. Then their pharmacokinetics in vivo was compared. Results showed that the received liposome was milky white suspension, spherical or ellipsoidal in shape. The mean particle size was 203 +/- 5 nm and the entrapment efficiency was 53.5 +/- 0.16%. The cefaquinom sulfate solution and liposome both followed a two compartment model, in vivo. The pharmacokinetic parameters for the solution and liposomal formulations were measured as follows: t(1/2 alpha) were (1.214 +/- 0.135) h and (1.395 +/- 0.113) h, t(1/2 beta) were (8.752 +/- 0.846) h and (16.503 +/- 1.275) h, AUC((0-24)) were (49.582 +/- 9.173) (mg.h)/L and (138.727 +/- 11.034) (mg.h)/L, CL/F were (0.357 +/- 0.015) L/(h.kg) and (0.127 +/- 0.012) L/(h.kg), MRT(0-24) were (2.68 +/- 0.229) h and (5.945 +/- 0.479) h, respectively. It could be clearly seen that t(1/2 beta) of liposome prolonged (p < 0.05), AUC and MRT both increased remarkably (p < 0.01), CL/F decreased. Results indicated that this preparation has more residence time and exhibits some sustained-release tendency.

Preparation and Characterization of Cefquinome Sulfate Microparticles for Transdermal Delivery by Negative-Pressure Cavitation Antisolvent Precipitation

Preparation of Cefquinome Nanoparticles by Using the Supercritical Antisolvent Process

Cefquinome Controlled Size Submicron Particles Precipitation by Seds Process Using Annular Gap Nozzle

Preparation and Characterization of Three Types of Cefquinome-Loaded Microspheres

Preparation and Characterization of Nanoparticles of Amorphous Cefmenoxime Hydrochloride

Quality Control of Cefquinome Sulfate Emulsion

Preparation and Testing of Cefquinome-Loaded Poly Lactic-Co-glycolic Acid Microspheres for Lung Targeting.

Preparation and characterization of lung-targeting cefquinome-loaded PLGA microspheres

Study of Preparation of Water-Soluble Cefadroxil Microparticles Based on Supercritical Fluid Technique

Preparation Of Cefquinome Sulfate Proliposome And Its Pharmacokinetics In Rabbit

Experimental Investigation on the Micronization of Aqueous Cefadroxil by Supercritical Fluid Technology

Pharmacokinetics and Tissue Distribution of Cefquinome Sulfate in Rats After I. V. Administration of Liposomal and Injectable Formulations

Preparation and characterization of micronized trans-cinnamic acid by anti-solvent crystallization method

Reverse Antisolvent Method to Avoid Jelly-like Phase Generation and Preparation of Crystalline Cefquinome

Preparation of cefquinome sulfate cationic proliposome and evaluation of its efficacy on Staphylococcus aureus biofilm.

Preparation by Antisolvent Recrystallization Method and Characterization of Coenzyme Q10 Microparticles

Enhancement of bioavailability of cefpodoxime proxetil using different polymeric microparticles

Preparation of cefuroxime axetil particles by supercritical CO2 anti-solvent technology

Preparation and dissolution of cefixime solid dispersion

The formation and solubilization of cefuroxime axetil solid dispersion

Preparation and evaluation of quercetin-loaded lecithin-chitosan nanoparticles for topical delivery.